THE STRUCTURAL REALITY & PRIVATE SENIOR LIVING · US
Your residents' families chose you because they expect more than management.
The data says they're watching closely.
Healos™ cellular nutrition program for private Assisted Living & Memory Care · Florida & New York
91
Day Program ·
20
High-risk residents
20
Measurable Outcomes
| ~68% of cardiac residents | On statins — CoQ10 depleted 40–50%. Fatigue prevents rehab completion. |
| ~52% on loop diuretics | K · Mg · Thiamine depleted. Electrolyte-driven arrhythmia and weakness. |
| 40–50% of cardiac patients | Clinical fear of recurrence. Untracked. Multiplies all other risk (×0.4). |
| Complex polypharmacy | 3–6 concurrent medications typical. Drug-nutrient conflicts compound. |
| No GP access (6.5M Canadians) | Residents waiting for LTC often have no regular physician to intercept decline. |
| Healos™ Trial: 20 patients | Targets all five mechanisms simultaneously. 3-month measurable outcome. |
🛡 All protocols pharmacist-reviewed against complex polypharmacy regimens 📋 Monthly H-Index report for every enrolled resident — shareable with clinical team
🔒 HIPAA & PIPEDA · Private Firestore Vault per resident 📊 Contractual inflammation targets — measurable, verifiable outcomes
THE STRUCTURAL CRISIS - THE NUMBERS
The Waiting List Won't Shorten
Until Your Current Residents Get Better.
These are the structural conditions driving the LTC capacity crisis. Healos™ is designed specifically for this gap
— not as wellness, but as a measurable cellular health intervention for your highest-risk residents.
87.9%
· US assisted living occupancy 2026 — revenue lost in the empty 12.1%
22 months
Average resident length of stay — shortened by unmanaged decline
41%
Annual staff turnover rate — driven by reactive, high-intensity care burden
$5,419/mo
Median private-pay monthly fee — at risk when families move loved ones out
The mechanism: When AL and memory care residents have unaddressed drug-nutrient depletions, subclinical inflammation, and mitochondrial energy deficits — they decline faster, generate more acute care transfers, require more intensive staff intervention per shift, and leave sooner. Each of these outcomes directly reduces your revenue, increases your operational cost, and shortens the tenure of the residents your team worked hard to admit.
Healos™ addresses all four mechanisms simultaneously — in a structured, pharmacist-reviewed, monthly-tracked program.
THE HEALOS™ LTC TRIAL PROPOSAL
20 high-risk residents. 3 months.
Measurable outcomes before you commit to anything larger.
The Trial is structured to protect your institution. You select the patients. You set the
outcome expectations. We deliver the data. The long-term contract is conditional on
hitting the agreed targets.
The 20-Patient · 3-Month · LTC Trial
Structured to demonstrate measurable outcome before full institutional commitment
WHAT THE TRIAL MEANS FOR EACH DECISION-MAKER
CEO / EXECUTIVE DIRECTOR
Occupancy, Length of stay & competitive positioning
Every 1-point improvement in resident quality of life adds an average 85 days to length of stay — at $5,419/month, that is $15,000+ in additional revenue per resident
Measurable reduction in per-resident acute care transfer events — the highest single-incident cost in private AL operations
First community in your market offering structured cellular health tracking — a documented differentiator for family decision-makers comparing facilities
91-day outcome data package suitable for family communication, board reporting, and marketing collateral
DIRECTOR OF CARE (DOC)
Resident stability & care team burden
Monthly H-Index™ report per resident — a clinical picture between physician visits, shareable with attending MD
hs-CRP and CoQ10 blood panel before/after comparison at Day 91 — objective inflammation data in the resident record
Drug-nutrient interaction review for residents on 5+ concurrent medications — flags unaddressed polypharmacy gaps before they become acute events
AI-automated daily tracking — near-zero additional nursing workload; no protocol changes required for your floor team
Marketing DIRECTOR (DOM)
Family satisfaction, referral reputation & move-in conversion
J.D. Power 2025 data shows family satisfaction with AL/memory care is driven by dining, resident activities, and visible wellbeing — precisely what cellular health improvement delivers
Documented resident health improvement creates the referral story families actually tell: “She’s stronger than when she moved in”
91-day outcome report gives your sales team a concrete, data-backed answer to the #1 family objection: “Will my parent actually improve here?”
As acuity levels continue to rise in AL and memory care, a proactive outcome-driven model is the competitive separator operators are looking for — Healos™ gives your community that narrative with verifiable data seniorhousingnews
Healos™ nutritional formulations are dietary supplements compliant with FDA DSHEA framework · No prescription required ·
Pharmacist-reviewed against resident medication profiles
TRIAL SEQUENCE
Step 1
Patient Selection
DOC identifies 20 high-risk residents: elevated hs-CRP · multiple cardiac medications · transfer-risk flags · functional plateau
Step 2
H-Index baseline + pharmacist review
32-dimension baseline audit for each resident. Full drug-nutrient interaction screen before any supplement is introduced. Warfarin/anticoagulant patients screened first.
Step 3
3-month protocol + monthly reporting
3-stage cellular protocol delivered. Monthly H-Index PDF per resident for your clinical team. 24/7 AI monitoring. Day-45 mid-point data review.
Step 4
Day-91 outcome report & contract decision
Full before/after blood panel comparison. H-Index 91-day arc. Clinical outcome summary. If targets met — long-term contract for 100+ patients offered.
We will respond personally within 48 hours · Proposal includes full pricing, target metrics, and contract terms
INSTITUTIONAL ECONOMICS
The economics of the Healos™ institutional model
How the Healos™ Sovereign Node partnership changes the economics of long-term care delivery
— for institutions that integrate it as a structured resident health programme.
Institutional partnership enquiries: Healos™ is building a network of private senior living partners across Florida and New York. The 20-resident Trial is the entry point — the long-term programme (full community, 80–150+ residents) is what the partnership becomes. Nutritional formulations are dietary supplements compliant with the FDA DSHEA framework · Pharmacist-reviewed against resident medication profiles · No prescription required · NPN application in progress with Health Canada for Canadian institutional partners.
Contact us directly for a proposal specific to your community's size, resident population, and current care metrics.
Healos™ Patient Programmes
Can Healos™ Replace My Doctor or Statin? No. Here's Why | Healos™
Can Healos Replace My Doctor or My Statin? No, and Here's Why
We hear it often, usually phrased kindly: "I'd rather do this naturally. Could Healos™ replace my statin?" Or from a family member: "Mum doesn't like taking pills. Could this be instead?"
It's an understandable wish. It's also a question a nutrition company could be tempted to answer vaguely. We won't.
Here is the short answer. No. Healos™ can't replace your doctor, your statin or any prescribed heart medicine, and we'd never ask you to stop one. Statins lower major vascular events by about a fifth for every 1 mmol/L drop in LDL; no supplement has matched that. Healos™ is complementary: it supports nutrients your medicines and surgery can deplete, plus the daily habits between appointments, alongside your treatment.
简短的答案： 我们常听到这样的问题，通常问得很客气：「我更想用自然的方法，Healos™ 能代替我的他汀吗？」或者家属问：「妈妈不喜欢吃药，这个能代替吗？」这是可以理解的愿望，也是一家营养公司可能想含糊回答的问题——我们不会。不能。Healos™ 不能替代你的医生、他汀或任何处方心脏药物，我们也绝不会要求你停用任何一种；LDL 每降低 1 mmol/L，他汀使主要血管事件减少约五分之一，没有任何补充剂达到过；Healos™ 是辅助性的，在治疗之外支持药物和手术可能消耗的营养素，以及复诊之间的日常习惯。
What heart medicines do that nutrition can't
Statins lower LDL cholesterol and stabilise plaque. Each 1 mmol/L reduction in LDL reduced major vascular events by about 22% in a pooled analysis of large trials (Cholesterol Treatment Trialists' Collaboration, Lancet, 2010).
Antiplatelets and anticoagulants prevent the clots that cause heart attacks and strokes, including inside a new stent.
Blood pressure medicines are the single biggest lever against stroke.
By contrast, large trials of common supplements, such as vitamin D and omega-3 in VITAL, didn't lower major cardiovascular events (Manson et al., NEJM, 2019; see why supplements alone don't fix heart disease). That's not a reason to dismiss nutrition. It's a reason to put it in its proper place.
心脏药物能做到、营养做不到的事： 他汀降低 LDL 并稳定斑块，大型试验汇总分析中 LDL 每降低 1 mmol/L，主要血管事件减少约 22%（Lancet 2010）；抗血小板药和抗凝药预防导致心梗和卒中的血栓，包括新支架内的血栓；降压药是预防卒中最大的杠杆。相比之下，常见补充剂的大型试验（如 VITAL 中的维生素 D 和 Omega-3）没有降低主要心血管事件（NEJM 2019）。这不是轻视营养的理由，而是把它放在正确位置的理由。
Why stopping medicines is risky
Stopping is common and quiet: in Ontario, only about 40% of older adults were still taking a statin two years after an acute coronary syndrome (Jackevicius et al., JAMA, 2002). LDL rises back within weeks, and stopping after a heart attack has been linked with more repeat events. Many people stop because of side effects, yet in the SAMSON trial about 90% of the symptoms people reported on statins also appeared on placebo (Wood et al., NEJM, 2020).
If a medicine doesn't agree with you, the answer is a conversation with your doctor about switching, adjusting or adding alternatives, not replacing it with supplements (see statins for life).
为什么停药有风险： 停药很常见，也很安静：在安大略，急性冠脉综合征两年后只有约 40% 的老年人仍在服用他汀（JAMA 2002）；LDL 几周内回升，心梗后停药与更多再发事件相关。很多人因副作用停药，但 SAMSON 试验中，服他汀期间报告的症状约 90% 在安慰剂期间同样出现（NEJM 2020）。如果药物不适合你，答案是和医生讨论换药、调整或加用替代药物，而不是用补充剂代替。
Where Healos™ does fit
Healos™ fills the part of recovery that medicines and procedures aren't designed to cover:
Nutrients your medicines and surgery can deplete, such as CoQ10 with statins or magnesium with some diuretics, replaced at doses matched to your medication list and pharmacist-reviewed before your kit ships.
The body's oxidative load after procedures, and the daily foundations of sleep, movement, food and stress.
Structure between appointments, with follow-ups at day 30 and day 60 (with a reminder to book your blood test) and a blood-test report review at day 90, and a summary for your doctor.
Think of it as together, not instead: your medicines protect the arteries; Healos™ supports the person taking them (see what Healos does, and doesn't do).
Healos™ 真正适合的位置： Healos™ 填补药物和手术本来不负责的那部分康复：药物和手术可能消耗的营养素，比如服他汀时的 CoQ10、服部分利尿剂时的镁，按用药清单匹配剂量，发货前经药剂师审核；手术后体内的氧化负担，以及睡眠、活动、饮食和压力这些日常基础；复诊之间的结构，第 30 天跟进、第 60 天跟进并提醒验血、第 90 天验血报告解读，并提供给医生的摘要。
可以把它理解为「一起，而不是代替」：药物保护动脉，Healos™ 支持吃药的这个人。
How to talk with your doctor about it
Say what matters to you: "I want to do everything I can alongside my medicines."
Bring your full medication and supplement list, including Healos.
If a medicine bothers you, describe the symptoms and ask about alternatives rather than stopping.
Ask which numbers to watch, such as LDL, blood pressure and HbA1c, and bring your Healos summary to show progress.
如何和医生谈这件事： 说出你在意的：「我想在服药之外尽我所能」；带上完整的药物和补充剂清单，包括 Healos；如果某种药让你不舒服，描述症状并询问替代方案，而不是自己停药；问清要关注哪些数字，比如 LDL、血压和 HbA1c，并带上 Healos™ 摘要展示进展。
The bottom line
Healos™ can't replace your doctor or your statin, and no supplement has matched what proven heart medicines do. What Healos™ can do is support you alongside them: replacing nutrients your treatment can deplete, strengthening daily foundations and giving the months between appointments a structure you can share with your care team. Together, not instead.
结论： Healos™ 不能替代你的医生或他汀，也没有任何补充剂达到经过验证的心脏药物的效果。Healos™ 能做的，是在药物之外支持你：补回治疗可能消耗的营养素、加强日常基础，并为复诊之间的几个月提供可以与医疗团队分享的结构。一起，而不是代替。
Frequently asked questions
Can supplements replace my statin? No. Statins reduce major vascular events by about 22% per 1 mmol/L drop in LDL, and no supplement has matched that in trials. Supplements can support you alongside a statin, not instead of it.
Can I stop my heart medicine if I take Healos™? No. Healos™ never asks you to stop or change a medicine. If a medicine causes side effects, talk to your doctor about adjusting or switching.
Is there a natural alternative to statins? Diet and lifestyle lower LDL modestly and matter a lot, but they don't replace statins for people with heart disease or high risk. If statins don't suit you, prescription alternatives such as ezetimibe or PCSK9 inhibitors exist.
How does Healos™ work with my medicines? Every kit is pharmacist-reviewed against your medication list, and Healos focuses on nutrients your medicines and surgery can deplete, alongside your treatment.
常见问题：
补充剂能代替他汀吗？不能，他汀使 LDL 每降 1 mmol/L 主要血管事件减少约 22%，没有补充剂达到。
用了 Healos™ 能停心脏药吗？不能，Healos™ 从不要求停药或改药，有副作用请找医生调整。
有他汀的天然替代品吗？饮食和生活方式能适度降低 LDL，很重要，但不能替代心脏病或高风险人群的他汀，不耐受时有依折麦布、PCSK9 抑制剂等处方选择。
Healos™ 如何与药物配合？每份营养包经药剂师按用药清单审核，聚焦药物和手术可能消耗的营养素。
References
Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol. Lancet. 2010;376(9753):1670–1681.
Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–467.
Wood FA, et al. N-of-1 trial of a statin, placebo, or no treatment to assess side effects (SAMSON). New England Journal of Medicine. 2020;383:2182–2184.
Manson JE, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease (VITAL). New England Journal of Medicine. 2019;380:33–44.
Healos™ Canada — Integrative cellular recovery for post-cardiac, post-stroke, and ACHD patients.
Canada.USA.Mexico.Japan.China.Singapore.Australia...
SMS & voicemail: 365.909.2567
Ottawa, Ontario, Canada
PATIENT SERVICES
© 2026 Healos™ Canada · NoHeartAttack.com · Ottawa, Ontario Privacy - Terms - Refunds
Healos™ programmes are dietary supplements and integrative wellness services. They are not medical advice, not medical treatment, and not a substitute for professional medical care.
Always consult your physician, cardiologist, or pharmacist before starting any new supplement programme. In case of cardiac emergency, call 911 immediately. Healos™ Canada